Oncoplastic reduction mammaplasty, an effective and safe method of breast conservation - 25/04/18
Abstract |
INTRODUCTION |
Oncoplastic breast conserving surgery (BCS) can enhance both cosmetic and oncologic breast cancer outcomes. This study evaluates the outcomes and complications associated with oncoplastic reduction mammaplasty performed by surgical breast oncologists.
METHODS |
A single institution retrospective chart review of patients undergoing oncoplastic reduction mammaplasty by a surgical breast oncologist for the treatment of breast cancer.
RESULTS |
Seventy-one patients were identified. The average patient age was 59.6 years (range 37–77 years). Average lesion span was 31.4 mm (range 3–166 mm). Six (8.5%) patients required additional surgery to obtain adequate margins. One (1.4%) patient developed recurrent disease during the follow-up interval. No major surgical complications were observed.
CONCLUSION |
Oncoplastic reduction mammaplasty is associated with low rates of re-excision and complications and can be safely and effectively performed by appropriately trained surgical breast oncologists.
El texto completo de este artículo está disponible en PDF.Highlights |
• | Oncoplastic surgery expands the indications for breast conservation. |
• | Oncoplastic surgery can be offered to patients despite presence of comorbidities. |
• | Reduction mammaplasty has excellent cosmetic and oncologic outcomes. |
• | Surgical breast oncologists can effectively perform reduction mammaplasties. |
Esquema
Vol 215 - N° 5
P. 910-915 - mai 2018 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?